124 related articles for article (PubMed ID: 38272207)
1. GRP78 Downregulation in Keratinocytes Promotes Skin Inflammation through the Recruitment and Activation of CCR6
Zhao L; Li J; Jiang B; Yang J; Lan J; Li D; Wen J; Xia Y; Nie W; Wang Z; Lv Y; Zeng F; Li Y; Shen G; Lei P; Tao J
J Invest Dermatol; 2024 Jul; 144(7):1557-1567.e11. PubMed ID: 38272207
[TBL] [Abstract][Full Text] [Related]
2. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
3. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.
Yoshiki R; Kabashima K; Honda T; Nakamizo S; Sawada Y; Sugita K; Yoshioka H; Ohmori S; Malissen B; Tokura Y; Nakamura M
J Invest Dermatol; 2014 Jul; 134(7):1912-1921. PubMed ID: 24569709
[TBL] [Abstract][Full Text] [Related]
4. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
Front Immunol; 2021; 12():635076. PubMed ID: 34025642
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.
Hammerich L; Bangen JM; Govaere O; Zimmermann HW; Gassler N; Huss S; Liedtke C; Prinz I; Lira SA; Luedde T; Roskams T; Trautwein C; Heymann F; Tacke F
Hepatology; 2014 Feb; 59(2):630-42. PubMed ID: 23959575
[TBL] [Abstract][Full Text] [Related]
7. High fat diet exacerbates murine psoriatic dermatitis by increasing the number of IL-17-producing γδ T cells.
Nakamizo S; Honda T; Adachi A; Nagatake T; Kunisawa J; Kitoh A; Otsuka A; Dainichi T; Nomura T; Ginhoux F; Ikuta K; Egawa G; Kabashima K
Sci Rep; 2017 Oct; 7(1):14076. PubMed ID: 29074858
[TBL] [Abstract][Full Text] [Related]
8. IL-38 Ameliorates Skin Inflammation and Limits IL-17 Production from γδ T Cells.
Han Y; Mora J; Huard A; da Silva P; Wiechmann S; Putyrski M; Schuster C; Elwakeel E; Lang G; Scholz A; Scholz T; Schmid T; de Bruin N; Billuart P; Sala C; Burkhardt H; Parnham MJ; Ernst A; Brüne B; Weigert A
Cell Rep; 2019 Apr; 27(3):835-846.e5. PubMed ID: 30995480
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
Sun J; Zhao Y; Hu J
PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
[TBL] [Abstract][Full Text] [Related]
10. Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis.
Mabuchi T; Takekoshi T; Hwang ST
J Immunol; 2011 Nov; 187(10):5026-31. PubMed ID: 21984702
[TBL] [Abstract][Full Text] [Related]
11. IL-17-Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin.
Campbell JJ; Ebsworth K; Ertl LS; McMahon JP; Newland D; Wang Y; Liu S; Miao Z; Dang T; Zhang P; Charo IF; Singh R; Schall TJ
J Immunol; 2017 Nov; 199(9):3129-3136. PubMed ID: 28972090
[TBL] [Abstract][Full Text] [Related]
12. The CCL20 and CCR6 axis in psoriasis.
Furue K; Ito T; Tsuji G; Nakahara T; Furue M
Scand J Immunol; 2020 Mar; 91(3):e12846. PubMed ID: 31692008
[TBL] [Abstract][Full Text] [Related]
13. Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.
Getschman AE; Imai Y; Larsen O; Peterson FC; Wu X; Rosenkilde MM; Hwang ST; Volkman BF
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12460-12465. PubMed ID: 29109267
[TBL] [Abstract][Full Text] [Related]
14. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
[TBL] [Abstract][Full Text] [Related]
15. Development of psoriasis by continuous neutrophil infiltration into the epidermis.
Katayama H
Exp Dermatol; 2018 Oct; 27(10):1084-1091. PubMed ID: 30019426
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
17. Understanding the impact of risankizumab on keratinocyte-derived IL-23A in a novel organotypic 3D skin model containing IL-23A responsive and IL-17A producing γδ-T-cells.
Huth L; Amann PM; Marquardt Y; Jansen M; Baron JM; Huth S
Cutan Ocul Toxicol; 2024 Jun; 43(2):124-128. PubMed ID: 38284163
[TBL] [Abstract][Full Text] [Related]
18. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
[TBL] [Abstract][Full Text] [Related]
19. Vγ4 γδ T Cells Provide an Early Source of IL-17A and Accelerate Skin Graft Rejection.
Li Y; Huang Z; Yan R; Liu M; Bai Y; Liang G; Zhang X; Hu X; Chen J; Huang C; Liu B; Luo G; Wu J; He W
J Invest Dermatol; 2017 Dec; 137(12):2513-2522. PubMed ID: 28733202
[TBL] [Abstract][Full Text] [Related]
20. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells.
Haas JD; González FH; Schmitz S; Chennupati V; Föhse L; Kremmer E; Förster R; Prinz I
Eur J Immunol; 2009 Dec; 39(12):3488-97. PubMed ID: 19830744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
